1
|
Villers A, Bommelaere T, Puech P, Ploussard G, Labreuche J, Leroy X, Olivier J. Risk estimation of metastatic recurrence after prostatectomy: A model using preoperative MRI and targeted biopsy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)00761-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Open
|
2
|
Bommelaere T, Villers A, Puech P, Ploussard G, Labreuche J, Drumez E, Leroy X, Olivier J. Individualized risk prediction of metastatic recurrence in patients candidate to radical prostatectomy: A new model using clinical, mri and mri-guided biopsy parameters. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00699-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
3
|
Vamour N, Gasmi A, Leroy X, Puech P, Koussa M, Villers A, Fantoni JC, Doumerc N, Bensalah K, Olivier J, Khene ZE. Impact of positive vascular margins status after surgical resection of non-metastatic renal cell carcinoma with caval tumour thrombus: A propensity score multicentre study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01082-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
4
|
Dahan LS, Giorgi R, Vergez S, Le Taillandier de Gabory L, Costes-Martineau V, Herman P, Poissonnet G, Mauvais O, Malard O, Garrel R, Uro-Coste E, Barry B, Bach C, Chevalier D, Mouawad F, Merol JC, Bastit V, Thariat J, Gilain L, Dufour X, Righini CA, Moya-Plana A, Even C, Radulesco T, Michel J, Baujat B, Fakhry N, Albert S, Andry G, Babin E, Bach C, Badet JM, Badoual C, Baglin A, Banal A, Barry B, Baudin E, Baujat B, Bensadoun R, Bertolus C, Bessède JP, Blanchard D, Borel C, Bozorg-Grayeli A, Breheret R, Breton P, Brugel L, Calais G, Casiraghi O, Cassagnau E, Castillo L, Ceruse P, Chabolle F, Chevalier D, Chobaut J, Choussy O, Cosmidis A, Coste A, Costes V, Crampette L, Darrouzet V, Demez P, Dessi P, Devauchelle B, Dolivet G, Dubrulle F, Duflo S, Dufour X, Faivre S, Fakhry N, Ferron C, Floret F, de Gabory L, Garrel R, Geoffrois L, Gilain L, Giovanni A, Girod A, Guerrier B, Hans S, Herman P, Hofman P, Housset M, Jankowski R, Jegoux F, Juliéron M, Kaminsky MC, Kolb F, St Guily JL, Laccoureye L, Lallemant B, Lang P, Lartigau E, Lavieille JP, Lefevre M, Leroy X, Malard O, Massip F, Mauvais O, Merol JC, Michel J, Mom T, Morinière S, de Monès E, Moulin G, Noel G, Poissonnet G, Prades JM, Radulesco T, de Raucourt D, Reyt E, Righini C, Robin YM, Rolland F, Ruhin B, Sarroul N, Schultz P, Serrano E, Sterkers O, Strunski V, Sudaka A, Tassart M, Testelin S, Thariat J, Timochenko A, Toussaint B, Coste EU, Valette G, Van den Abbeele T, Varoquaux A, Veillon F, Vergez S, Wassef M. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases. Eur J Surg Oncol 2021; 47:1376-1383. [DOI: 10.1016/j.ejso.2020.11.123] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Revised: 10/31/2020] [Accepted: 11/13/2020] [Indexed: 12/18/2022] Open
|
5
|
Jarry E, Fantoni J, Puech P, Leroy X, Villers A. Hémangiome anastomotique du hile rénal : prise en charge chirurgicale par laparoscopie robot-assistée. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
6
|
Brugat T, Rugeri B, Hommet G, Dumont A, Baron L, Halter C, Sémache M, Mancini A, Amalric C, Giambelluco M, Lenne N, Sidhoum M, Franchet C, Mayer S, Leroy X, Schann S. OP0236 RELEVANCE OF BIASED PAR2 INHIBITORS IN REDUCING INFLAMMATION AND CARTILAGE DEGRADATION IN IN VITRO AND IN VIVO MODELS OF RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Protease-activated receptor-2 (PAR2) is a member of a family of G-protein-coupled receptors involved in multiple physiological mechanisms. Compelling evidences have unravelled the key roles of PAR2 in the pathology of both rheumatoid arthritis (RA) and osteoarthritis (OA)1. Indeed, in vitro, in vivo and ex vivo experiments showed that this receptor promotes inflammation, cartilage erosion (and subsequent bone degradation), and pain. However, the signalling pathways involved in these functions are not well understood2. This is of importance as some pathways can promote the pathogenesis3while others prevent it4. We developed a new series of small molecules as novel biased PAR2 inhibitors to treat rheumatic diseases.Objectives:To evaluate the efficacy and mechanism of action of new biased PAR2 inhibitors on cartilage erosion and inflammation.Methods:The potency of compounds to inhibit human PAR2 signalling was evaluated in vitro by FLIPR calcium assay in HEK293 cells. The same assay was used to determine their selectivity over human PAR1 and PAR4 as well as murine versions of PAR2. The effect of several PAR2 inhibitors on 9 signalling pathways (Gi2, GoB, Gz, Gq, G13, G14, G15, B arrestin 2, EPAC) was evaluated by the BRET-based bioSens-All™ technology. In vitro anti-hypertrophic effect was determined by measuring the mRNA level of type II collagen, aggrecan and MMP13 in rat chondrocytes after IL1β stimulation. In vitro anti-inflammatory effect was determined by measuring the secretion of IL6, IL8, IL1β, TNFα and IFNγ by human monocytes. In vivo, the pharmacodynamic of our small molecules was assessed after intravenous and oral administration. Therapeutic efficacy of a compound was then evaluated in a collagen-induced arthritis model in DBA1/J mice. In this model, measures of the arthritis index score, body weight, plasma level of TNFα, IL6, IL8 and IL1β and histological evaluation of cartilage erosion were performed.Results:Our new series of small molecules are potent PAR2 inhibitors (IC50<1nM in calcium assay) with some selectivity over PAR1 and PAR4. Our compounds significantly inhibited PAR2 mediated recruitment of Gz, Gq, G13, G14 and G15. However, surprisingly, these small molecules had no effect on B arrestin 2, EPAC, Gi2 and GoB demonstrating that they are biased inhibitors. The effect of our compounds on PAR2 signalling was clearly different from 3 already existing PAR2 inhibitors described in the literature (I-117, AZ3451 and P2pal-18s). We compared the in vitro anti-hypertrophic effect on chondrocyte and anti-inflammatory effect on monocytes of these compounds to determine the importance of PAR2 signalling pathways in these cellular functions. In vivo, our small molecules had good bioavailability after oral administration of 10mg/kg in mice (clearance = 0.038L/h/kg; T½ = 9.9h; AUC= 162564 ng.h/mL; Cmax = 9005 ng/mL). The in vivo therapeutic efficacy of a biased PAR2 inhibitor in a model of collagen-induced arthritis will be presented.Conclusion:Our results show the potency of biased PAR2 inhibitors to reduce both the inflammation and cartilage erosion in rheumatoid arthritis. They confirm the huge potential of PAR2 as a therapeutic target and unravel the relevance of biased antagonism of this receptor to treat rheumatic diseases.References:[1]McCulloch et al., Frontiers in Endocrinology, 2018;2Hollenberg et al., British Journal of Pharmacology, 2014;3Sharma et al., Genes and Immunity, 2015;4Rayees et al., Cell Reports, 2019Disclosure of Interests:Thibaut Brugat Employee of: Domain Therapeutics, Baptiste Rugeri Employee of: Domain Therapeutics, Gaël Hommet Employee of: Domain Therapeutics, Alexia Dumont Employee of: Domain Therapeutics, Luc Baron Employee of: Domain Therapeutics, Célia Halter Employee of: Domain Therapeutics, Meriem Sémache Employee of: Domain Therapeutics, Arturo Mancini Employee of: Domain Therapeutics, Camille Amalric Employee of: Domain Therapeutics, Marie Giambelluco Employee of: Domain Therapeutics, Nathalie Lenne Employee of: Domain Therapeutics, Marjorie Sidhoum Employee of: Domain Therapeutics, Christel Franchet Employee of: Domain Therapeutics, Stanislas Mayer Employee of: Domain Therapeutics, Xavier Leroy Employee of: Domain Therapeutics, Stephan Schann Employee of: Domain Therapeutics
Collapse
|
7
|
Delporte G, Olivier J, Ruffion A, Crouzet S, Cavillon C, Helfrich O, Leroy X, Villers A. [Evolution of the number of incident cases, stage and first treatments for prostate cancer in France between 2001 and 2016]. Prog Urol 2019; 29:108-115. [PMID: 30638756 DOI: 10.1016/j.purol.2018.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2018] [Revised: 10/14/2018] [Accepted: 12/12/2018] [Indexed: 10/27/2022]
Abstract
INTRODUCTION No studies of French hospital registries for prostate cancer (PCa) have been published since the 2012 USPSTF recommendations. MATERIAL This is a multicenter cohort study based on hospital data of prostate biopsies (PB) in 3 health centers between 2001 and 2016. The main objective is to describe the evolution of incident cases of PCa. The secondary objectives are to describe the number of cases per stage of PCa and the distribution of the first treatments. RESULTS In total, 11,491 PB series diagnosed 5927 cases of PCa. The median age was 67 [61-73] years and the median PSA was 7.8 [5.5-13] ng/mL. The number of cases increased until 2006 before decreasing from 2006 to 2013 and then stabilizing from 2013 to 2016. The proportion of incident cases was: (1) for the stable metastatic stage around 8 [7-10]%, (2) for cases with PSA<10 ng/mL increasing from 46% to 75% in 2010 down to 64% in 2016, (3) for the grade 1 group decreasing from 59% to 33 % between 2011 and 2016. The proportion of active surveillance treatment for low-risk cancers increased from 5 to 60% and surgery decreased from 73 to 33%. CONCLUSION The evolution of the incident cases showed a decrease from 2006 to 2013 and a stability until 2016. The number of cases with PSA<10 ng/mL decreased since 2010 and the proportion of the options of treatment by surveillance increased strongly to the detriment of the surgery for low risks. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- G Delporte
- Service d'urologie, université de Lille, CHU de Lille, 59000 Lille, France.
| | - J Olivier
- Service d'urologie, université de Lille, CHU de Lille, 59000 Lille, France
| | - A Ruffion
- Service d'urologie, centre hospitalier Lyon-sud, hospices civiles de Lyon, 69310 Pierre-Bénite, France
| | - S Crouzet
- Service d'urologie, hôpital Edouard-Herriot, hospices civiles de Lyon, 69003 Lyon, France
| | - C Cavillon
- Service d'urologie, polyclinique Saint-François-Saint-Antoine, 03100 Montluçon, France
| | - O Helfrich
- Service d'urologie, université de Lille, CHU de Lille, 59000 Lille, France
| | - X Leroy
- Service d'anatomo-pathologie, université de Lille, CHU de Lille, 59000 Lille, France
| | - A Villers
- Service d'urologie, université de Lille, CHU de Lille, 59000 Lille, France
| |
Collapse
|
8
|
Annoot A, Olivier J, Valtille P, Deken V, Leroy X, Puech P, Villers A. Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer. World J Urol 2018; 37:261-268. [DOI: 10.1007/s00345-018-2442-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Accepted: 08/07/2018] [Indexed: 02/06/2023] Open
|
9
|
Kamoun A, Cancel-Tassin G, Fromont G, Elarouci N, Armenoult L, Ayadi M, Irani J, Leroy X, Villers A, Fournier G, Doucet L, Boyault S, Brureau L, Multigner L, Diedhiou A, Roupret M, Compérat E, Blanchet P, de Reyniès A, Cussenot O. Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease. Ann Oncol 2018; 29:1814-1821. [DOI: 10.1093/annonc/mdy224] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
|
10
|
Martin-Malburet A, Marcq G, Leroy X, Guiffart P, Fantoni JC, Flamand V, Villers A, Puech P, Ouzzane A. [Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision]. Prog Urol 2018; 28:425-433. [PMID: 29789235 DOI: 10.1016/j.purol.2018.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2017] [Revised: 02/21/2018] [Accepted: 03/28/2018] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To analyze, in patients with prostate cancer (PC) potentially eligible for active surveillance (AS), whether multiparametric-MRI (mp-MRI) predicts presence of clinically significant cancer on radical prostatectomy (RP) specimen. METHODS We identified 77 men with PC eligible for AS (PSA≤15ng/mL, stage≤T2a, Gleason score≤6, up to 3 positive cores, maximal cancer core length≤5mm) who underwent RP between 01/2008 and 08/2015. All patients had prebiopsy mp-MRI followed by systematic±targeted biopsies. For each patient, the likelihood of the presence of cancer on mp-MRI was assigned using Likert scale (1 to 5). The predictive factors for the presence of significant cancer on RP specimen (Gleason score≥7 and/or tumoral maximal diameter>10mm) were evaluated using logistic regression. RESULTS Median age was 61 and median PSA was 6.7ng/mL. Overall, 49 (64%) patients had a positive mp-MRI (score≥3). Clinically significant cancer on RP specimen was found in 45 (58%) patients (69% in MRI-positive patients vs 39% in MRI-negative patients). In multivariate analysis, a positive MRI was a predictive factor for the presence of significant cancer on the surgical specimen (OR=3.0; CI95% [1.01-8.88]; P=0.04), as was age (OR=1.17; CI95% [1.05-1.31]; P=0.004) and PSAD (OR=1.10; CI95% [1.01-1.20]; P=0.02). CONCLUSION Mp-MRI is a useful exam for selecting patients eligible for AS even if the situation remains unclear after prostate biopsies including targeted biopsies. Upon confirmation by further studies, mp-MRI should be considered as an independent criterion before entering an AS program. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- A Martin-Malburet
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France.
| | - G Marcq
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| | - X Leroy
- Service d'anatomopathologie, CHRU Lille, 59800 Lille, France
| | - P Guiffart
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| | - J-C Fantoni
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| | - V Flamand
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| | - A Villers
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| | - P Puech
- Service d'uro-radiologie, hôpital Claude Huriez, CHRU Lille, 59800 Lille, France
| | - A Ouzzane
- Service d'urologie, hôpital Claude Huriez, CHRU Lille, rue Michel Polonovski, 59000 Lille, France
| |
Collapse
|
11
|
Marcq G, Pinçon C, Jérôme R, Fantoni J, Aubert S, Leroy X, Villers A. Recueil et analyse d’une cohorte de prostatectomies totales pour cancers de prostate diagnostiqués par IRM et biopsies : prévalence, caractéristiques morphométriques et histopathologiques des cancers antérieurs. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Colson C, Aubry E, Cartigny M, Rémy AA, Franquet H, Leroy X, Kéchid G, Lefèvre C, Besson R, Cools M, Spinoit A, Sultan C, Manouvrier S, Philibert P, Ghoumid J. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-
mutated patient's management. Clin Genet 2017; 92:99-103. [DOI: 10.1111/cge.12957] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Revised: 12/08/2016] [Accepted: 12/10/2016] [Indexed: 11/26/2022]
Affiliation(s)
- C. Colson
- CHU Lille; Clinique de Génétique Guy Fontaine; Lille France
- EA 7364, RADEME, Maladies RAres du Développement et du Métabolisme: du phénotype au génotype et à la Fonction; Université de Lille; Lille France
| | - E. Aubry
- CHU Lille; Service de Chirurgie Viscérale Pédiatrique; Lille France
| | - M. Cartigny
- EA 7364, RADEME, Maladies RAres du Développement et du Métabolisme: du phénotype au génotype et à la Fonction; Université de Lille; Lille France
- CHU Lille; Service d'Endocrinologie Pédiatrique; Lille France
| | - A.-A. Rémy
- CHU Lille; Clinique de Génétique Guy Fontaine; Lille France
- CHU Lille; Service d'Endocrinologie Pédiatrique; Lille France
| | - H. Franquet
- CHU Lille; Institut de pathologie; Lille France
| | - X. Leroy
- EA 7364, RADEME, Maladies RAres du Développement et du Métabolisme: du phénotype au génotype et à la Fonction; Université de Lille; Lille France
- CHU Lille; Institut de pathologie; Lille France
| | - G. Kéchid
- CHU Lille; Pédopsychiatrie; Lille France
| | - C. Lefèvre
- CHU Lille; Service d'Endocrinologie Pédiatrique; Lille France
| | - R. Besson
- CHU Lille; Service de Chirurgie Viscérale Pédiatrique; Lille France
| | - M. Cools
- Endocrinologie & Diabetologie voor kinderen en adolescenten; Universitair Ziekenhuis Gent; Belgium
| | | | - C. Sultan
- Département de Biochimie et Hormonologie; CHU Montpellier; France
- Université de Montpellier; CNRS UPR 1142 Institut de génétique Humaine, Equipe “Développement et Pathologie de la Gonade”; Montpellier France
| | - S. Manouvrier
- CHU Lille; Clinique de Génétique Guy Fontaine; Lille France
- EA 7364, RADEME, Maladies RAres du Développement et du Métabolisme: du phénotype au génotype et à la Fonction; Université de Lille; Lille France
| | - P. Philibert
- Département de Biochimie et Hormonologie; CHU Montpellier; France
- Université de Montpellier; CNRS UPR 1142 Institut de génétique Humaine, Equipe “Développement et Pathologie de la Gonade”; Montpellier France
| | - J. Ghoumid
- CHU Lille; Clinique de Génétique Guy Fontaine; Lille France
- EA 7364, RADEME, Maladies RAres du Développement et du Métabolisme: du phénotype au génotype et à la Fonction; Université de Lille; Lille France
| |
Collapse
|
13
|
Prasivoravong J, Barbotin AL, Derveaux A, Leroy C, Leroy X, Puech P, Mitchell V, Marcelli F, Rigot JM. Leydig cell tumor of the testis with azoospermia and elevated delta4 androstenedione: case report. Basic Clin Androl 2016; 26:14. [PMID: 27833751 PMCID: PMC5100078 DOI: 10.1186/s12610-016-0041-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Accepted: 09/14/2016] [Indexed: 12/27/2022] Open
Abstract
Background Secreting interstitial cell (Leydig cell) tumors are rare. In adults, the clinical picture and steroid levels are variable. Case presentation This paper presents a case of left testicular tumor, showing azoospermia with normal serum level of total testosterone, collapsed FSH and LH, and high delta4 androstenedione. Histopathological investigation revealed a Leydig cell tumor. TESE allowed spermatozoa extraction and freezing. Testicular histology found hypospermatogenesis and germ-cell aplasia with interstitial fibrosis. Surgical resection of the tumor resulted in normalization of gonadotropins and fall in serum delta4 androstenedione to subnormal levels in the postoperative period confirming that the tumor was secreting delta4 androstenedione. It was hypothesized that high delta4 androstenedione resulted in intra tumoral 17 β-HSD overtaken by delta4 androstenedione or that 17 β-HSD activity in the tumor was different from that of normal Leydig cells. Three months after surgery sperm analysis found a complete recovery of spermatogenesis. A spontaneous pregnancy occurred 3 months after surgery and a girl was born. Conclusions In this case, the diagnosis of testicular Leydig cell tumor secreting delta4 androstenedione was made in a context of azoospermia.
Collapse
Affiliation(s)
- J Prasivoravong
- Department of Andrology, Lille University Hospital, Lille, France ; Department of Andrology, CHRU Lille, Hôpital Calmette, Boulevard du Professeur Leclercq, 59037 Lille Cedex, France
| | - A-L Barbotin
- Biology of Reproduction Unit, Lille University Hospital, Lille, France ; EA4308 Gametogenesis and Gamete Quality, University of Lille, Lille, France
| | - A Derveaux
- Department of Andrology, Lille University Hospital, Lille, France
| | - C Leroy
- Department of Andrology, Lille University Hospital, Lille, France
| | - X Leroy
- Department of Pathology, Lille University Hospital, Lille, France
| | - P Puech
- Department of Radiology, Lille University Hospital, Lille, France
| | - V Mitchell
- Biology of Reproduction Unit, Lille University Hospital, Lille, France ; EA4308 Gametogenesis and Gamete Quality, University of Lille, Lille, France
| | - F Marcelli
- Department of Andrology, Lille University Hospital, Lille, France ; EA4308 Gametogenesis and Gamete Quality, University of Lille, Lille, France
| | - J-M Rigot
- Department of Andrology, Lille University Hospital, Lille, France ; EA4308 Gametogenesis and Gamete Quality, University of Lille, Lille, France
| |
Collapse
|
14
|
Raichi A, Villers A, Marcq G, Fantoni J, Leroy X, Puech P, Ouzzane A. Évaluation de l’IRM dans la sélection et le suivi des patients pris en charge par surveillance active pour cancer de prostate localisé à faible risque de progression. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Plouvier S, Villers A, Ballereau C, Ligier K, Leduc F, Leroy X, Pasquier D, Bonnal J. Épidemiologie et prise en charge des tumeurs de la vessie dans la zone de proximité de Lille : étude en population générale. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Depeyre A, Brygo A, Leroy X, Gryselein R, Ferri J. [Osteoid osteoma of zygomatic bone: Case report and literature review]. ACTA ACUST UNITED AC 2016; 117:442-445. [PMID: 27519792 DOI: 10.1016/j.revsto.2016.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2016] [Accepted: 06/22/2016] [Indexed: 10/21/2022]
Abstract
INTRODUCTION Osteoid osteoma is a benign osseous tumor affecting mainly young men. Although it develops essentially in long bones, some cases occurring in face, mainly in mandible, were related. To our knowledge, only one single case was described in zygomatic bone. OBSERVATION A 71-year-old man consulted for a right periorbital pain evolving since months with night recrudescence. The pain was not relieved by standard analgesics. Clinical examination was strictly normal. CT scan showed a low-density bone lesion surrounded by a peripheral osseocondensation line within the body of the right zygoma with intense uptake at bone scintigraphy. The patient benefited from surgical excision of the lesion. Pain stopped immediately. Histological examination assessed an osteoid osteoma. DISCUSSION Zygomatic localization and late occurrence are rare concerning osteoid osteomas. Many ways of management have been reported but surgical excision remains the gold standard.
Collapse
Affiliation(s)
- A Depeyre
- Service de chirurgie maxillofaciale et stomatologie, hôpital Salengro, CHRU de Lille, avenue Émile-Laine, 59037 Lille cedex, France; Service de chirurgie maxillofaciale et stomatologie, hôpital Estaing, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France.
| | - A Brygo
- Service de chirurgie maxillofaciale et stomatologie, hôpital Salengro, CHRU de Lille, avenue Émile-Laine, 59037 Lille cedex, France
| | - X Leroy
- Service d'anatomie pathologique, hôpital Salengro, CHRU de Lille, avenue Émile-Laine, 59037 Lille cedex, France
| | - R Gryselein
- Service de chirurgie maxillofaciale et stomatologie, hôpital Salengro, CHRU de Lille, avenue Émile-Laine, 59037 Lille cedex, France
| | - J Ferri
- Service de chirurgie maxillofaciale et stomatologie, hôpital Salengro, CHRU de Lille, avenue Émile-Laine, 59037 Lille cedex, France
| |
Collapse
|
17
|
Aubert S, Duchene F, Augusto D, Llinares K, Lemaitre L, Gosselin B, Leroy X. Low-grade Tubular Myxoid Renal Tumors: A Clinicopathological Study of 3 Cases. Int J Surg Pathol 2016; 12:179-83. [PMID: 15173928 DOI: 10.1177/106689690401200216] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We report 3 cases of a new renal cell tumor entity with a review of the literature. These 3 cases were retrieved from the files of this institution from 1991 to 2002. The clinical data and all histologic slides were reviewed and an immunohistochemical study was performed. Patients were all females. Tumors were almost similar with well-defined margins. Tumor architecture was tubular and focally fusiform with an abundant myxoid stroma. Tumor cells were low cuboidal, slightly eosinophilic with low nuclear grade. Immunohistochemistry was in favor of a distal nephron differentiation. All patients were healthy after surgery. We describe 3 cases of a new clinicopathological entity entitled low-grade tubular myxoid renal tumor with a benign clinical course.
Collapse
Affiliation(s)
- S Aubert
- Department of Pathology, University Hospital, Lille, France
| | | | | | | | | | | | | |
Collapse
|
18
|
Mortuaire G, Leroy X, Gengler I, Chevalier D, Prin L, Picry A. Histopathological classification of refractory chronic rhinosinusitis with nasal polyps. Histol Histopathol 2015; 30:1447-54. [PMID: 25986951 DOI: 10.14670/hh-11-632] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To delineate the histopathological characteristics of nasal mucosa in refractory chronic rhinosinusitis with nasal polyps (CRSwNP) in order to demonstrate subtypes of nasal polyps and their potential relation with lower airway comorbidity. STUDY DESIGN Clinical- and pathological-based cross-sectional study Methods: Nasal polyp specimens were prospectively collected from patients with refractory CRSwNP referred to our institution for endoscopic sinus surgery. Oral and topical steroids were stopped 1 month before surgery. The pathological analysis was conducted by 2 independent reviewers with light microscopy on Hematoxylin-Eosin-Saffron stained slides. Each observer fulfilled a standardized protocol with cell count and stromal characterization on the most representative field. Mean grading scores were established. Morphological aspects were compared with the cell distribution and the clinical conditions. RESULTS Among 36 patients, three subtypes of nasal polyps were depicted: eosinophilic edematous (64%), fibrous (9%) and intermediate with mixed edematous and collagen stromal structure (27%). Basement membrane thickening and seromucous gland hyperplasia were observed in the fibrosis sub-type (p<0.03). Eosinophilic mucosal infiltrate was significantly increased (p=0.026) in patients with concomitant pulmonary disease (n=21). Nasal polyp distribution was not influenced by asthma, allergy, previous surgery and smoking. CONCLUSION Our 3-subtype classification of refractory CRSwNP in Caucasian population shows a predominant edematous structure whatever the clinical conditions may have been. Eosinophilia as a major factor of adaptive immune response in nasal inflammation is a feature of concomitant pulmonary disease. Further studies concerning mucosal remodelling and outcome assessment after sinus surgery are required to evaluate the impact of our classification on a daily basis.
Collapse
Affiliation(s)
- G Mortuaire
- Otorhinolaryngology - Head and Neck Surgery Department, University Hospital of Lille, France and EA 2686- French Eosinophil Network, University Hospital of Lille, Lille, France.
| | - X Leroy
- Pathology Department, University Hospital of Lille, France. Lille
| | - I Gengler
- Otorhinolaryngology - Head and Neck Surgery Department, University Hospital of Lille, Lille, France
| | - D Chevalier
- Otorhinolaryngology - Head and Neck Surgery Department, University Hospital of Lille, Lille, France
| | - L Prin
- EA 2686- French Eosinophil Network, University Hospital of Lille, Lille, France
| | - A Picry
- Otorhinolaryngology - Head and Neck Surgery Department, University Hospital of Lille, Lille, France
| |
Collapse
|
19
|
Rizk J, Ouzzane A, Flamand V, Fantoni J, Leroy X, Villers A. Résultats carcinologiques après prostatectomie totale pour cancer par voie ouverte et laparoscopique avec ou sans assistance robotisée : résultats à 10 ans. Prog Urol 2014; 24:866. [DOI: 10.1016/j.purol.2014.08.182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
20
|
Varinot J, Colin P, Rouprêt M, Leroy X, Comperat E. Anatomopathologie des tumeurs de la voie excrétrice urinaire supérieure : état de l’art pour le rapport annuel de l’Association française d’urologie. Prog Urol 2014; 24:954-65. [DOI: 10.1016/j.purol.2014.07.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Revised: 06/27/2014] [Accepted: 07/06/2014] [Indexed: 11/28/2022]
|
21
|
Elbaz J, Wiss A, Raoul G, Leroy X, Ferri J. Mandibular condylar hyperplasia: correlation between clinical, radiologic, scintigraphic and histologic features. Int J Oral Maxillofac Surg 2013. [DOI: 10.1016/j.ijom.2013.07.673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
22
|
Tian TV, Tomavo N, Huot L, Flourens A, Bonnelye E, Flajollet S, Hot D, Leroy X, de Launoit Y, Duterque-Coquillaud M. Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. Oncogene 2013; 33:2204-14. [PMID: 23708657 DOI: 10.1038/onc.2013.176] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2012] [Revised: 02/27/2013] [Accepted: 03/18/2013] [Indexed: 12/17/2022]
Abstract
Prostate cancer (PCa) is one of the major public health problems in Western countries. Recently, the TMPRSS2:ERG gene fusion, which results in the aberrant expression of the transcription factor ERG, has been shown to be the most common gene rearrangement in PCa. Previous studies have determined the contributions of this fusion in PCa disease initiation and/or progression in vitro and in vivo. In this study on TMPRSS2:ERG regulation in PCa, we used an androgen receptor and TMPRSS2:ERG fusion double-negative PCa cell model: PC3c. In three cell clones with different TMPRSS2:ERG expression levels, ectopic expression of the fusion resulted in significant induction of cell migration and invasion in a dose-dependent manner. In agreement with this phenotype, high-throughput microarray analysis revealed that a set of genes, functionally associated with cell motility and invasiveness, were deregulated in a dose-dependent manner in TMPRSS2:ERG-expressing cells. Importantly, we identified increased MMP9 (Metalloproteinase 9) and PLXNA2 (Plexin A2) expression in TMPRSS2:ERG-positive PCa samples, and their expression levels were significantly correlated with ERG expression in a PCa cohort. In line with these findings, there was evidence that TMPRSS2:ERG directly and positively regulates MMP9 and PLXNA2 expression in PC3c cells. Moreover, PLXNA2 upregulation contributed to TMPRSS2:ERG-mediated enhancements of PC3c cell migration and invasion. Furthermore, and importantly, PLXNA2 expression was upregulated in metastatic PCa tumors compared with localized primary PCa tumors. This study provides novel insights into the role of the TMPRSS2:ERG fusion in PCa metastasis.
Collapse
Affiliation(s)
- T V Tian
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France [4] Faculté de Médecine Henri Warembourg, Université du Droit et de la Santé Lille II, Lille, France
| | - N Tomavo
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France
| | - L Huot
- 1] Institut Pasteur de Lille/IFR142, Lille, France [2] Université de Lille Nord de France, Lille, France [3] Centre d'Infection et d'Immunité de Lille (CIIL), INSERM U1019, CNRS UMR8204, Lille, France
| | - A Flourens
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France
| | | | - S Flajollet
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France
| | - D Hot
- 1] Institut Pasteur de Lille/IFR142, Lille, France [2] Université de Lille Nord de France, Lille, France [3] Centre d'Infection et d'Immunité de Lille (CIIL), INSERM U1019, CNRS UMR8204, Lille, France
| | - X Leroy
- 1] Université de Lille Nord de France, Lille, France [2] Faculté de Médecine Henri Warembourg, Université du Droit et de la Santé Lille II, Lille, France [3] Centre hospitalier régional et universitaire de Lille, Institut de Pathologie, Lille, France
| | - Y de Launoit
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France
| | - M Duterque-Coquillaud
- 1] Institut de Biologie de Lille, CNRS UMR8161, Lille, France [2] Institut Pasteur de Lille/IFR142, Lille, France [3] Université de Lille Nord de France, Lille, France
| |
Collapse
|
23
|
Bozzini G, Colin P, Betrouni N, Maurage CA, Leroy X, Simonin S, Martin-Schmitt C, Villers A, Mordon S. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model. Photodiagnosis Photodyn Ther 2013; 10:296-303. [PMID: 23993856 DOI: 10.1016/j.pdpdt.2013.01.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Revised: 01/10/2013] [Accepted: 01/13/2013] [Indexed: 10/27/2022]
Abstract
OBJECTIVES To evaluate photodynamic therapy (PDT) using 5-ALA-induced protoporphyrin IX (PPIX) in an in vivo hypoxic tumor model and its monitoring using MRI. MATERIAL AND METHODS Dunning R3327-AT2 tumors were grafted in the neck of Copenhagen rats. PDT using 150 mg 5-ALA/kg i.v. was performed by focal interstitial illumination of the photosensitized tumor (λ=633 nm; fluence=100 J/cm(2)). MRI at baseline and 2 days after treatment (T1, T2 and dynamic gadolinium enhanced sequences) were performed. Necrosis volumes were determined on post-procedure MRI. Tumors were resected 2 days post-PDT and obtained necrosis was determined histopathologically. Intra-tumoral PPIX distribution was evaluated using confocal microscopy and tissue porphyrin quantification. RESULTS Twenty rats were treated divided into three groups: continuous (n=7), fractionated illumination (n=7), and a control group receiving only light or only ALA or neither (n=6). Baseline MRI confirmed the hypoxic character of tumors. Necrosis volumes determined on posttreatment MRI were not reproducible and presented with important geometric and volumetric variability. Average necrosis volumes of 0.39 cc (0-0.874 cc) in the continuous group, 0.24 cc (0.107-0.436 cc) in the fractionated group and 0.012 cc (0-0.071 cc) in the control group were observed. Intra-tumoral PPIX distribution was heterogeneous and PPIX quantification revealed low intra-tumoral concentration. CONCLUSION Necrosis volumes induced by 5-ALA-mediated PDT were highly variable and non reproducible, probably because of lack of intra-tissular oxygen. Photosensitizer was poorly represented inside the tumor and its distribution was heterogeneous. Our study suggests that 5-ALA-mediated PDT might not be the best management option for hypoxic prostatic adenocarcinoma.
Collapse
Affiliation(s)
- G Bozzini
- Lille University Hospital, Department of Urology, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Broucqsault A, Ouzzane A, Leroy X, Lemaitre L, Zini L. [Small renal masses: 10 years of treatment in a tertiary referral center in cancer research]. Prog Urol 2012; 22:692-700. [PMID: 22999115 DOI: 10.1016/j.purol.2012.04.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2011] [Revised: 11/03/2011] [Accepted: 04/19/2012] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To analyze the impact of preoperative clinical data that could influence the undertaking of small renal masses (size<4cm) and to direct patients towards surgery or observance or radiofrequency. PATIENTS AND METHODS From January 2000 to December 2010, 253 small renal masses were included in a retrospective study. Renal masses less than 3cm were compared to the 3 to 4cm masses. Clinical data, pathological data and follow-up was noted prospectively on the database and we analyzed it according to the treatment done (surgery, radiofrequency or observation). RESULTS Surgical treatment, radiofrequency and observation were performed for 214 (86.4%), 15 (5.9%), and 24 (9.5%) patients respectively. The treatments of the patients differed in the two groups (<3cm vs. 3-4cm) and the appeal to radiofrequency and observation was more frequent for elder patients (>65years old) and for those whom performance status (ECOG status) greater or equal to 1. Cancer specific survival was not statistically different for the two groups (average: 87.5% after 5years, mean 33months follow-up, P=0.7). Independent risk factors of recurrence were Fuhrman grade, synchronous tumors, noddles invasion and metastatic progression. Positive surgical margins were not a risk factor of recurrence (P=0.6). CONCLUSION Age and performance status are the two main clinical data, which influence the treatment for patients with small renal masses. Radiofrequency and observation were undertaken more regularly for elder and altered ones. The use of scales as Charlson Index or Lee scale could help to choose more easily according to global morbidity and mortality.
Collapse
Affiliation(s)
- A Broucqsault
- Service d'urologie, université Lille Nord de France, hôpital Huriez, CHU de Lille, Lille, France
| | | | | | | | | |
Collapse
|
25
|
Sufana Iancu A, Colin P, Puech P, Villers A, Ouzzane A, Fantoni JC, Leroy X, Lemaitre L. Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI. World J Urol 2012; 31:13-9. [DOI: 10.1007/s00345-012-0945-7] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2012] [Accepted: 09/07/2012] [Indexed: 10/27/2022] Open
|
26
|
Bouillez A, Butruille C, Ringot B, Gnemmi V, Van Seuningen I, Zini L, Leroy X, Aubert A, Perrais M. 344 The MUC1 Membrane-bound Mucin is an Actor in Renal Clear-cell Carcinoma. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71034-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Ligier K, Plouvier S, Danzon A, Martin P, Benoît E, Molinié F, Launoy G, Buisset E, Leroy X, Chevalier D, Chaud P, Chérié-Challine L. [Elements of completeness and results of the first year of registration of the "Registre général des cancers de Lille et de sa région"]. Rev Epidemiol Sante Publique 2012; 60:131-9. [PMID: 22424751 DOI: 10.1016/j.respe.2011.10.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2011] [Revised: 09/12/2011] [Accepted: 10/05/2011] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND In 2005, following the first cancer plan of the national health authorities, a general cancer registry was established in northern France, in a territory designated as a "zone in proximity to the city of Lille" (ZPL). The aim of the present work was to evaluate the completeness of the registry's first year of incident cancer registration (2005) and to compare the observed cancer incidence in the "ZPL" with the estimated incidence in France. METHODS Completeness was assessed using the average number of sources per case, the percentage of histological verification and a method of independent case ascertainment (mortality/incidence ratio). A direct standardization on the world population was used to calculate the ZPL/France ratios of standardized incidence rates. Analyses were conducted for 21 cancer sites. RESULTS In 2005, 3635 cases of invasive cancer were recorded by the registry. The average number of sources per case was 2.7 and histological proof was available for 91.4% of cases. Mortality/incidence ratios showed satisfactory completeness of the data for men for most cancer sites. For women however, for cancer sites for which the number of cases was low, data will have to be confirmed during the subsequent years of observation. A lack of completeness was found for cutaneous melanoma. In men, an overincidence was identified for cancers of lip-mouth-pharynx, larynx, esophagus, lung, liver, bladder, kidney and colon-rectum. In women, an overincidence has been identified for cancers of lip-mouth-pharynx, liver, bladder, colon-rectum, corpus uteri and ovaries. CONCLUSION The first year of incidence validated at the "Registre général des cancers de Lille et de sa région" shows a completeness of records with regards to studied criteria. The comparison with national data shows an overincidence of cancers related to tobacco and alcohol consumption in the geographical area covered by the registry. The incidence of lip-mouth-pharynx cancer in men is the highest of all French registries.
Collapse
Affiliation(s)
- K Ligier
- Registre général des cancers de Lille et de sa région, centre de référence régional en cancérologie, 235, avenue de la Recherche, CS 50086, 59373 Loos cedex, France.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Ghoneim TP, Ouzzane A, Leroy X, Lemaitre L, Berthon N, Fantoni JC, Villers A, Zini L. [Renal cell carcinoma of patients younger than 40 years old]. Prog Urol 2012; 22:93-9. [PMID: 22284593 DOI: 10.1016/j.purol.2011.11.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2011] [Revised: 10/17/2011] [Accepted: 11/24/2011] [Indexed: 01/13/2023]
Abstract
CONTEXT Clinical and pathological characteristics of renal cell carcinoma (RCC) of patients younger than 40 years old are not well known. The objective of this study was to analyze these characteristics by comparison to a group of patients aged 58 to 62. METHODS Retrospective study of a group of patients aged less than 40 years old (group 1, n=44) and a group of patients aged 58 to 62 years old (group 2; n=106) treated surgically for a renal mass from January 2000 to July 2009. A comparative analysis of clinical, pathological characteristics and of cancer-specific survival was performed. Specific survival was calculated with the Kaplan-Meier method and compared with the Log-Rank test. Univariate and multivariable analysis were performed to assess and quantify the effect of age on cancer-specific survival. Covariates were gender, age group, tumor size, pT stage, histological sub-type and Fuhrman grade. RESULTS Clinical and pathological characteristics were similar in both groups (P>0.05) except for histological sub-type (56% of clear cell RCC for group 1 versus 82% for group 2). In the group of patients younger than 40 years, translocation RCC represented 23% of all RCCs. Cancer-specific survival at five years was similar in both groups (80% and 76% for group 1 and 2 respectively, P>0.58). Fuhrman grade was the only independent prognostic factor of cancer-specific survival (P=0.001). CONCLUSION Patients younger than 40 years were more likely to have a translocation RCC than their older counterparts for who clear cell RCC represented the main histological sub-type. Cancer-specific survival was similar between both groups. Only a systematic specific immunostaining for TFE3 or TFEB will allow to assess the exact incidence and prognosis of this entity.
Collapse
Affiliation(s)
- T P Ghoneim
- Service d'urologie, université de Lille Nord-de-France, hôpital Claude Huriez, CHU de Lille, 2, rue Michel-Polonovski, 59000 Lille, France.
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Butruille C, Marcelli F, Ghoneim T, Lemaitre L, Puech P, Leroy X, Rigot JM. Prise en charge des nodules testiculaires dans une population de patients infertiles. Prog Urol 2012; 22:45-52. [DOI: 10.1016/j.purol.2011.08.030] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2011] [Revised: 08/17/2011] [Accepted: 08/19/2011] [Indexed: 11/26/2022]
|
30
|
Verhasselt-Crinquette M, Colin P, Ouzzane A, Robin YM, Villers A, Ansart H, Aubert S, Leroy X. L’amplification de HER2 dans les carcinomes urothéliaux de la voie excrétrice urinaire supérieure est rare mais constitue une cible thérapeutique potentielle. Ann Pathol 2011. [DOI: 10.1016/j.annpat.2011.09.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
31
|
Broucqsault A, Ouzzane A, Launay D, Leroy X, Rose C, Villers A, Fantoni JC. Hématopoïèse extramédullaire rénale. Prog Urol 2011; 21:575-9. [DOI: 10.1016/j.purol.2010.11.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2010] [Revised: 11/05/2010] [Accepted: 11/21/2010] [Indexed: 01/12/2023]
|
32
|
Mordon S, Colin P, Betrouni N, Makni N, Nevoux P, Ouzzane A, Puech P, Lemaitre L, Leroy X, Villers A. Focal treatment of prostate cancer with vascular-targeted photodynamic therapy. Photodiagnosis Photodyn Ther 2011. [DOI: 10.1016/j.pdpdt.2011.03.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
33
|
Ben Haj Amor M, Nectoux E, Basraoui D, Cagneaux M, Leroy X, Herbaux B, Gabor F, Boutry N. [Solitary calcified myofibroma of the leg: a case report]. ACTA ACUST UNITED AC 2011; 92:243-6. [PMID: 21501763 DOI: 10.1016/j.jradio.2011.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2010] [Revised: 11/11/2010] [Accepted: 02/10/2011] [Indexed: 11/15/2022]
|
34
|
Ouzzane A, Lemaitre L, Puech P, Leroy X, Nevoux P, Betrouni N, Mordon S, Haber G, Villers A. 856 ANTERIOR PROSTATE CANCERS DETECTED AT PREBIOPSY MRI AND DIAGNOSED BY TARGETED AND SYSTEMATIC 12-CORE BIOPSY. BIOPSY RESULTS AND CORRELATION WITH RADICAL PROSTATECTOMY SPECIMENS. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/s1569-9056(11)60842-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
35
|
Colin P, Estevez JP, Betrouni N, Ouzzane A, Puech P, Leroy X, Biserte J, Villers A, Mordon S. [Photodynamic therapy and prostate cancer]. Prog Urol 2010; 21:85-92. [PMID: 21296274 DOI: 10.1016/j.purol.2010.07.018] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2010] [Revised: 07/21/2010] [Accepted: 07/28/2010] [Indexed: 11/26/2022]
Abstract
PURPOSE Photodynamic therapy (PDT) is an innovative therapeutic modality in urologic oncology. MATERIAL AND METHODS We reviewed the current literature on principles and modalities of PDT in prostatic oncology. RESULTS Focal therapy of prostate cancer is an application field of PDT. Clinical phase II studies are ongoing to determine PDT efficacy and safety in this indication. PDT as salvage treatment after prostatic radiotherapy has been tested. Carcinologic results were promising but important side effects were reported. Individual dosimetric planification is necessary to avoid this toxicity. CONCLUSION PDT first clinical experience for prostate cancer has showed its technical feasibility. Several research ways are currently in study to improve carcinologic efficacy and to limit potential side effects.
Collapse
Affiliation(s)
- P Colin
- Inserm, U703, Université Nord de France, CHRU de Lille, 152, rue du Dr-Yersin, 59120 Loos, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Sechter C, Thebaud E, Rocourt N, Leblond P, Bonnevalle M, Leroy X, Defachelles A. P199 - Synovialosarcome rénal, une localisation tumorale à ne pas méconnaitre. Arch Pediatr 2010. [DOI: 10.1016/s0929-693x(10)70599-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
37
|
Ligier K, Leroy X, Martin P, Clisant S, Richard F, Penel N. Adult sarcomas: Incidence and initial management before implantation of regional sarcoma committee in northern France. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e20522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
38
|
Perrais M, Aubert S, Hémon B, Porchet N, Leroy X, Van Seuningen I. MUC1 is a target of hypoxia-inducible factor transcription factor in renal clear carcinomatous cells. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71327-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
39
|
Zini L, Leroy X, Lemaitre L, Devos P, Aubert S, Biserte J, Villers A. Tumour necrosis in chromophobe renal cell carcinoma: Clinical data to distinguish aggressive variants. Eur J Surg Oncol 2008; 34:687-91. [DOI: 10.1016/j.ejso.2007.08.010] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2007] [Accepted: 08/31/2007] [Indexed: 11/24/2022] Open
|
40
|
Proust-Lemoine E, Mitchell V, Deruelle P, Lamblin A, Néraud B, Leroy X, Leteurtre E, Dewailly D. Ectopic hyperprolactinaemia in a woman with a mesocolic perivascular epithelioid cell tumor ("PEComa"). Ann Endocrinol (Paris) 2008; 69:240-3. [PMID: 18395182 DOI: 10.1016/j.ando.2008.01.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2007] [Accepted: 01/23/2008] [Indexed: 11/29/2022]
Abstract
Ectopic prolactin secretion remains exceptional and originates mainly from malignant tumors. We report the case of a 47-year-old woman who presented amenorrhea leading to unravel important hyperprolactinaemia (269 ng/mL) with no hypothalamo-pituitary mass on magnetic resonance imaging (MRI). Pelvic imaging revealed the presence of a large pelvic mass that originated from the mesocolon. After complete surgical extraction, histological examination was in favour of a "perivascular epithelioid cell tumor" (PEComa). Prolactin levels normalized after surgical extraction and remained normal after a 3-year follow-up, totally free of tumour recurrence and/or metastasis. This suggests that hyperprolactinaemia was most likely related to the PEComa, despite negative reactions with antiprolactin antibodies at immunohistochemistry. Alternatively to a direct prolactin secretion by the tumor, one could hypothesize that the tumour secreted a prolactin stimulating factor or a dopamine antagonist that could not be identified. In conclusion, in face of an important hyperprolactinaemia without any hypothalamic-pituitary mass, it remains important to search for an ectopic prolactin production, such as a PEComa.
Collapse
Affiliation(s)
- E Proust-Lemoine
- Service d'endocrinologie et maladies métaboliques, clinique Marc-Linquette, 6, rue du Pr-Laguesse, CHRU de Lille, 59037 Lille cedex, France.
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ, Leroy X. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 2008; 52:483-93. [DOI: 10.1111/j.1365-2559.2008.02973.x] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
42
|
Leroy X, Farine MO, Buob D, Wacrenier A, Copin MC. Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma. Histopathology 2008; 51:874-6. [PMID: 18042078 DOI: 10.1111/j.1365-2559.2007.02874.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Leroy X, Petit ML, Fayoux P, Aubert S, Escande F. Aberrant diffuse expression of synaptophysin in a sinonasal alveolar rhabdomyosarcoma. Pathology 2007; 39:275-6. [PMID: 17454764 DOI: 10.1080/00313020701230781] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Zini L, Garnier-Destrieux L, Leroy X, Fantoni J, Lemaitre L, Biserte J, Villers A. POS-02.90: Preoperative prediction by imaging and prognostic significance of ostium renal vein invasion in renal cell carcinoma with inferior vena cava tumor thrombus. Urology 2007. [DOI: 10.1016/j.urology.2007.06.731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
45
|
Zini L, Leroy X, Aubert S, Lemaitre L, Fantoni C, Biserte J, Villers A. MP-16.21: Aggressive variants of chromophobe renal cell carcinoma: a clinico-pathological study of prognostic factors. Urology 2007. [DOI: 10.1016/j.urology.2007.06.481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
46
|
Mortuaire G, Pasquesoone X, Leroy X, Chevalier D. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract. Eur Arch Otorhinolaryngol 2006; 264:451-3. [PMID: 17089137 DOI: 10.1007/s00405-006-0189-5] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2006] [Accepted: 10/05/2006] [Indexed: 11/25/2022]
Abstract
We report the clinicopathologic features of two cases of respiratory epithelial adenomatoid harmartoma (REAH) of the sinonasal tract. Hamartomas are rare in the nasal cavity. Histologically, these lesions were characterized by a glandular proliferation lined by ciliated respiratory epithelium originated from the surface epithelium. The two patients were evaluated by a gastroenterologist to assess intestine colocalization. The treatment was a complete surgical resection through limited approach. We should be aware of this entity as a differential diagnosis for inverted papilloma and well-differenciated adenocarcinoma. Fine histopathological analysis is necessary to avoid aggressive surgery for this benign lesion.
Collapse
Affiliation(s)
- G Mortuaire
- Department of Otorhinolaryngology, Head and Neck Surgery, Claude Huriez Hospital Pr Chevalier, University of Lille, CHRU Lille, Lille, France.
| | | | | | | |
Collapse
|
47
|
Castillo C, Buob D, Mortuaire G, Chevalier D, Aubert S, Copin M, Leroy X. Adénocarcinomes à cellules indépendantes nasosinusiens. À propos de 5 cas. Ann Pathol 2006. [DOI: 10.1016/s0242-6498(06)78505-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Gonzalez S, Kerdraon O, Haddad O, Aubert S, Leroy X. Évaluation de la sous-stadification PT1A/PT1B et de l’immunomarquage p53/survivine pour le pronostic des carcinomes urothéliaux G3PT1. Ann Pathol 2006. [DOI: 10.1016/s0242-6498(06)78406-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Abstract
AIM To report the description of a rare benign osseous lesion affecting the ribs entitled post-traumatic fibro-osseous lesion (PTFOL). METHODS Seven cases of PTFOLs were retrieved from the archives of the University Hospital of Lille. Histological slides were reviewed and lesions were classified according to the histological patterns described by McDermott et al. Clinical and follow-up data were obtained from the patients' charts. RESULTS PTFOLs occurred principally in men (mean age 31.8 years) with a known or suspected previous chest injury for four of them. No previous cancer was noted. Radiologically, PTFOLs readily presented as an isolated expansive lucency with a sclerotic rim located on the last five ribs. A constant increased uptake of radionucleotide was noted on bone scan. Microscopically, two fibro-osseous, four xanthomatous and one mixed pattern were individualised. Lesions were characterised by a network of anastomosing bone trabeculae without osteoblast lining within a fibrous stroma. A zonal maturation from woven to peripheral lamellar bone was characterised. Central sheets of lipid-laden histiocytes were conspicuous in the xanthomatous type. For each patient, clinical follow-up was excellent, without any recurrence. CONCLUSIONS This is the second largest series of PTFOLs, which is considered to be a dysplastic healing process after trauma. It may be symptomatic or shown by imaging studies realised for unrelated reason. PTFOL is regularly misdiagnosed with other more common lesions of the ribs, such as fibro-osseous dysplasia, osteoma osteoid and benign fibrous histiocytoma. Its recognition is of importance because no follow-up is needed after resection.
Collapse
Affiliation(s)
- S Aubert
- Department of Pathology, University Hospital, CHRU, Lille, France.
| | | | | | | | | | | |
Collapse
|
50
|
Leroy X, Aubert S, Lemaitre L, Haffner J, Biserte J, Gosselin B. Multilocular cystic renal oncocytoma. J Clin Pathol 2006; 59:223-4. [PMID: 16443744 PMCID: PMC1860320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
|